<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Clin Trials[TA]</title><link>http://www.unboundmedicine.com/medline/ebm/journal/Clin_Trials</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Reformulating the hazard ratio to enhance communication with clinical investigators.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029217/full_citation/Reformulating_the_hazard_ratio_to_enhance_communication_with_clinical_investigators_</link><description>Buyse M <br/><span class="title">Reformulating the hazard ratio to enhance communication with clinical investigators. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):641-2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029217/full_citation/Reformulating_the_hazard_ratio_to_enhance_communication_with_clinical_investigators_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029217">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029217/Reformulating_the_hazard_ratio_to_enhance_communication_with_clinical_investigators_">Find Related Articles</a> </description></item><item><title>An analysis of the controversy over classical one-sided tests.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029216/full_citation/An_analysis_of_the_controversy_over_classical_one_sided_tests_</link><description>Freedman LS <br/><span class="title">An analysis of the controversy over classical one-sided tests. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):635-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029216/abstract/An_analysis_of_the_controversy_over_classical_one_sided_tests_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19029216/full_citation/An_analysis_of_the_controversy_over_classical_one_sided_tests_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029216">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029216/An_analysis_of_the_controversy_over_classical_one_sided_tests_">Find Related Articles</a> </description></item><item><title>Applying Hodges-Lehmann scale parameter estimates to hospital discharge times.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029215/full_citation/Applying_Hodges_Lehmann_scale_parameter_estimates_to_hospital_discharge_times_</link><description>Shuster JJ, Theriaque DW, Ilfeld BM <br/><span class="title">Applying Hodges-Lehmann scale parameter estimates to hospital discharge times. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):631-4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029215/abstract/Applying_Hodges_Lehmann_scale_parameter_estimates_to_hospital_discharge_times_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19029215/full_citation/Applying_Hodges_Lehmann_scale_parameter_estimates_to_hospital_discharge_times_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029215">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029215/Applying_Hodges_Lehmann_scale_parameter_estimates_to_hospital_discharge_times_">Find Related Articles</a> </description></item><item><title>Response to commentaries.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029214/full_citation/Response_to_commentaries_</link><description>Miller F, Joffe S <br/><span class="title">Response to commentaries. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):630.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029214/full_citation/Response_to_commentaries_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029214">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029214/Response_to_commentaries_">Find Related Articles</a> </description></item><item><title>Early phase clinical trials: communicating the uncertainties of ;magnitude of benefit' and ;likelihood of benefit'.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029213/full_citation/Early_phase_clinical_trials:_communicating_the_uncertainties_of_;magnitude_of_benefit'_and_;likelihood_of_benefit'_</link><description>Kass NE <br/><span class="title">Early phase clinical trials: communicating the uncertainties of ;magnitude of benefit' and ;likelihood of benefit'. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):627-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029213/full_citation/Early_phase_clinical_trials:_communicating_the_uncertainties_of_;magnitude_of_benefit'_and_;likelihood_of_benefit'_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029213">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029213/Early_phase_clinical_trials:_communicating_the_uncertainties_of_;magnitude_of_benefit'_and_;likelihood_of_benefit'_">Find Related Articles</a> </description></item><item><title>Comment regarding benefit in phase 1 oncology trials.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029212/full_citation/Comment_regarding_benefit_in_phase_1_oncology_trials_</link><description>Morse M <br/><span class="title">Comment regarding benefit in phase 1 oncology trials. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):626.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029212/full_citation/Comment_regarding_benefit_in_phase_1_oncology_trials_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029212">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029212/Comment_regarding_benefit_in_phase_1_oncology_trials_">Find Related Articles</a> </description></item><item><title>Varieties of uncertainty and the validity of informed consent.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029211/full_citation/Varieties_of_uncertainty_and_the_validity_of_informed_consent_</link><description>Weinfurt KP <br/><span class="title">Varieties of uncertainty and the validity of informed consent. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):624-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029211/full_citation/Varieties_of_uncertainty_and_the_validity_of_informed_consent_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029211">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029211/Varieties_of_uncertainty_and_the_validity_of_informed_consent_">Find Related Articles</a> </description></item><item><title>Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029210/full_citation/Benefit_in_phase_1_oncology_trials:_therapeutic_misconception_or_reasonable_treatment_option</link><description>Miller FG, Joffe S <br/><span class="title">Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option? [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):617-23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029210/abstract/Benefit_in_phase_1_oncology_trials:_therapeutic_misconception_or_reasonable_treatment_option">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19029210/full_citation/Benefit_in_phase_1_oncology_trials:_therapeutic_misconception_or_reasonable_treatment_option">Full Citation</a></description></item><item><title>Use of biological assignment in hematopoietic stem cell transplantation clinical trials.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029209/full_citation/Use_of_biological_assignment_in_hematopoietic_stem_cell_transplantation_clinical_trials_</link><description>Logan B, Leifer E, Bredeson C, et al. <br/><span class="title">Use of biological assignment in hematopoietic stem cell transplantation clinical trials. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):607-16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029209/abstract/Use_of_biological_assignment_in_hematopoietic_stem_cell_transplantation_clinical_trials_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19029209/full_citation/Use_of_biological_assignment_in_hematopoietic_stem_cell_transplantation_clinical_trials_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029209/Use_of_biological_assignment_in_hematopoietic_stem_cell_transplantation_clinical_trials_">Find Related Articles</a> </description></item><item><title>Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029208/full_citation/Adaptive_designs_for_dose_finding_in_non_cancer_phase_II_trials:_influence_of_early_unexpected_outcomes_</link><description>Resche-Rigon M, Zohar S, Chevret S <br/><span class="title">Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes. [Journal Article]</span><br/><span class="source" title="Clinical trials (London, England)">Clin Trials 2008; 5(6):595-606.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029208/abstract/Adaptive_designs_for_dose_finding_in_non_cancer_phase_II_trials:_influence_of_early_unexpected_outcomes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19029208/full_citation/Adaptive_designs_for_dose_finding_in_non_cancer_phase_II_trials:_influence_of_early_unexpected_outcomes_">Full Citation</a> | <a href="http://ctj.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19029208">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029208/Adaptive_designs_for_dose_finding_in_non_cancer_phase_II_trials:_influence_of_early_unexpected_outcomes_">Find Related Articles</a> </description></item></channel></rss>